NO150481C - Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater

Info

Publication number
NO150481C
NO150481C NO781772A NO781772A NO150481C NO 150481 C NO150481 C NO 150481C NO 781772 A NO781772 A NO 781772A NO 781772 A NO781772 A NO 781772A NO 150481 C NO150481 C NO 150481C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogy procedure
alkanolamine derivatives
active alkanolamine
Prior art date
Application number
NO781772A
Other languages
English (en)
Other versions
NO150481B (no
NO781772L (no
Inventor
Brian Geoffrey Main
Jeffrey John Barlow
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of NO781772L publication Critical patent/NO781772L/no
Publication of NO150481B publication Critical patent/NO150481B/no
Publication of NO150481C publication Critical patent/NO150481C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/14Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO781772A 1977-05-23 1978-05-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater NO150481C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2160877 1977-05-23

Publications (3)

Publication Number Publication Date
NO781772L NO781772L (no) 1978-11-24
NO150481B NO150481B (no) 1984-07-16
NO150481C true NO150481C (no) 1984-10-24

Family

ID=10165792

Family Applications (1)

Application Number Title Priority Date Filing Date
NO781772A NO150481C (no) 1977-05-23 1978-05-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater

Country Status (23)

Country Link
US (1) US4143140A (no)
JP (1) JPS53147038A (no)
AR (1) AR221844A1 (no)
AT (1) AT361938B (no)
AU (1) AU521677B2 (no)
BE (1) BE867376A (no)
CA (1) CA1085845A (no)
CH (1) CH643536A5 (no)
DE (1) DE2822473C2 (no)
DK (1) DK157994C (no)
ES (3) ES470108A1 (no)
FI (1) FI66856C (no)
FR (1) FR2391997A1 (no)
IE (1) IE47053B1 (no)
IL (1) IL54788A (no)
IT (1) IT1096311B (no)
MX (1) MX5546E (no)
NL (1) NL188900C (no)
NO (1) NO150481C (no)
NZ (1) NZ187340A (no)
PT (1) PT68076B (no)
YU (2) YU40981B (no)
ZA (1) ZA782927B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172150A (en) * 1977-05-23 1979-10-23 Imperial Chemical Industries Limited Cardiac stimulants
DE3270905D1 (en) * 1981-12-17 1986-06-05 Haessle Ab Para-substituted 3-phenoxy-1-carbonylaminoalkylamino-propan-2-ols having beta receptor blocking properties
EP0207036A1 (en) * 1985-06-20 1986-12-30 Aktiebolaget Hässle New para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylamino-propanol-2-s having beta receptor blocking properties.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT326107B (de) * 1935-11-15 1975-11-25 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen racemischen oder optisch aktiven n,n'-bis- (3-subst. phenoxy-2-hydroxy-1-propyl) -alpha,omega- diaminoalkanen sowie deren säureadditionssalzen
CH550771A (de) * 1970-10-30 1974-06-28 Hoffmann La Roche Verfahren zur herstellung von phenaethylaminderivaten.
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
ES478222A1 (es) 1979-11-01
YU41274B (en) 1986-12-31
ES478223A1 (es) 1979-11-01
NL7805562A (nl) 1978-11-27
FI781638A (fi) 1978-11-24
ZA782927B (en) 1979-06-27
IE47053B1 (en) 1983-12-14
DK228778A (da) 1978-11-24
NO150481B (no) 1984-07-16
IL54788A (en) 1981-06-29
IT7823706A0 (it) 1978-05-23
CA1085845A (en) 1980-09-16
DE2822473C2 (de) 1987-01-08
NZ187340A (en) 1981-05-01
YU123278A (en) 1983-01-21
JPS6259694B2 (no) 1987-12-12
PT68076B (en) 1979-11-21
AU521677B2 (en) 1982-04-22
DK157994C (da) 1990-08-27
YU40981B (en) 1986-10-31
JPS53147038A (en) 1978-12-21
US4143140A (en) 1979-03-06
ES470108A1 (es) 1979-10-01
DE2822473A1 (de) 1978-12-14
AT361938B (de) 1981-04-10
FI66856C (fi) 1984-12-10
FR2391997B1 (no) 1980-07-04
DK157994B (da) 1990-03-12
NL188900C (nl) 1992-11-02
PT68076A (en) 1978-06-01
IT1096311B (it) 1985-08-26
ATA375778A (de) 1980-09-15
MX5546E (es) 1983-10-04
IE781002L (en) 1978-11-23
YU218882A (en) 1983-01-21
FR2391997A1 (fr) 1978-12-22
NL188900B (nl) 1992-06-01
NO781772L (no) 1978-11-24
CH643536A5 (de) 1984-06-15
FI66856B (fi) 1984-08-31
AU3636978A (en) 1979-11-29
AR221844A1 (es) 1981-03-31
BE867376A (fr) 1978-11-23

Similar Documents

Publication Publication Date Title
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO147562C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO145656C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyletanolaminderivater